Consistently, in this study, we found that while DTX treatment alone promoted PCa cell apoptosis both in vitro and in vivo, the combined use of DD3-ZD55-SPAG9 and DTX significantly enhanced PCa cell apoptosis both in vitro and in vivo. The gene discussed is SPAG9; the disease is posterior cortical atrophy.